101 related articles for article (PubMed ID: 2974318)
1. Abnormal expression of the MOS proto-oncogene in human thyroid medullary carcinoma.
Parkar MH; Seid JM; Stringer BM; Ingemansson S; Woodhouse N; Goyns MH
Cancer Lett; 1988 Dec; 43(3):185-9. PubMed ID: 2974318
[TBL] [Abstract][Full Text] [Related]
2. Oncogene expression in a medullary thyroid carcinoma.
Klimpfinger M; Ruhri C; Pütz B; Pfragner R; Wirnsberger G; Höfler H
Virchows Arch B Cell Pathol Incl Mol Pathol; 1988; 54(4):256-9. PubMed ID: 2895537
[TBL] [Abstract][Full Text] [Related]
3. C-myc, N-myc, N-ras, and c-erb-B: lack of amplification or rearrangement in human medullary thyroid carcinoma and a derivative cell line.
Yang KP; Castillo SG; Nguyen CV; Hickey RC; Samaan NA
Anticancer Res; 1990; 10(1):189-92. PubMed ID: 2185686
[TBL] [Abstract][Full Text] [Related]
4. Involvement of RET oncogene in human tumours: specificity of RET activation to thyroid tumours.
Santoro M; Sabino N; Ishizaka Y; Ushijima T; Carlomagno F; Cerrato A; Grieco M; Battaglia C; Martelli ML; Paulin C
Br J Cancer; 1993 Sep; 68(3):460-4. PubMed ID: 8353035
[TBL] [Abstract][Full Text] [Related]
5. Structure and expression of nuclear oncogenes in multi-stage thyroid tumorigenesis.
Wyllie FS; Lemoine NR; Williams ED; Wynford-Thomas D
Br J Cancer; 1989 Oct; 60(4):561-5. PubMed ID: 2803926
[TBL] [Abstract][Full Text] [Related]
6. Expression of the ret proto-oncogene in human medullary thyroid carcinomas and pheochromocytomas of MEN 2A.
Miya A; Yamamoto M; Morimoto H; Tanaka N; Shin E; Karakawa K; Toyoshima K; Ishizaka Y; Mori T; Takai S
Henry Ford Hosp Med J; 1992; 40(3-4):215-9. PubMed ID: 1362408
[TBL] [Abstract][Full Text] [Related]
7. Low frequency of rearrangements of the ret and trk proto-oncogenes in Japanese thyroid papillary carcinomas.
Wajjwalku W; Nakamura S; Hasegawa Y; Miyazaki K; Satoh Y; Funahashi H; Matsuyama M; Takahashi M
Jpn J Cancer Res; 1992 Jul; 83(7):671-5. PubMed ID: 1381340
[TBL] [Abstract][Full Text] [Related]
8. Expression of c-erbA in human hepatocellular carcinomas.
Arbuthnot P; Kew M; Parker I; Fitschen W
Anticancer Res; 1989; 9(4):885-7. PubMed ID: 2554788
[TBL] [Abstract][Full Text] [Related]
9. Mutation analysis of the c-mos proto-oncogene and the endothelin-B receptor gene in medullary thyroid carcinoma and phaeochromocytoma.
Eng C; Foster KA; Healey CS; Houghton C; Gayther SA; Mulligan LM; Ponder BA
Br J Cancer; 1996 Aug; 74(3):339-41. PubMed ID: 8695346
[TBL] [Abstract][Full Text] [Related]
10. Structure and expression of c-myc and c-fos proto-oncogenes in thyroid carcinomas.
Terrier P; Sheng ZM; Schlumberger M; Tubiana M; Caillou B; Travagli JP; Fragu P; Parmentier C; Riou G
Br J Cancer; 1988 Jan; 57(1):43-7. PubMed ID: 3348948
[TBL] [Abstract][Full Text] [Related]
11. The Mos proto-oncogene maps near the centromere on mouse chromosome 4.
Propst F; Vande Woude GF; Jenkins NA; Copeland NG; Lee BK; Hunt PA; Eicher EM
Genomics; 1989 Jul; 5(1):118-23. PubMed ID: 2570024
[TBL] [Abstract][Full Text] [Related]
12. Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype.
Santoro M; Carlomagno F; Hay ID; Herrmann MA; Grieco M; Melillo R; Pierotti MA; Bongarzone I; Della Porta G; Berger N
J Clin Invest; 1992 May; 89(5):1517-22. PubMed ID: 1569189
[TBL] [Abstract][Full Text] [Related]
13. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas.
Komminoth P
Verh Dtsch Ges Pathol; 1995; 79():L-LV. PubMed ID: 8600671
[TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of RET/PTC3; a novel rearranged version of the RETproto-oncogene in a human thyroid papillary carcinoma.
Santoro M; Dathan NA; Berlingieri MT; Bongarzone I; Paulin C; Grieco M; Pierotti MA; Vecchio G; Fusco A
Oncogene; 1994 Feb; 9(2):509-16. PubMed ID: 8290261
[TBL] [Abstract][Full Text] [Related]
15. The ret proto-oncogene is consistently expressed in human pheochromocytomas and thyroid medullary carcinomas.
Santoro M; Rosati R; Grieco M; Berlingieri MT; D'Amato GL; de Franciscis V; Fusco A
Oncogene; 1990 Oct; 5(10):1595-8. PubMed ID: 1701232
[TBL] [Abstract][Full Text] [Related]
16. [Genetic causes of the thyroid carcinomas].
Jindrichová S; Vlcek P; Bendlová B
Cas Lek Cesk; 2004; 143(10):664-8. PubMed ID: 15584614
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic rearrangements of the RET proto-oncogene in papillary thyroid carcinomas from children exposed to the Chernobyl nuclear accident.
Fugazzola L; Pilotti S; Pinchera A; Vorontsova TV; Mondellini P; Bongarzone I; Greco A; Astakhova L; Butti MG; Demidchik EP
Cancer Res; 1995 Dec; 55(23):5617-20. PubMed ID: 7585643
[TBL] [Abstract][Full Text] [Related]
18. Functions of the mos oncogene family and associated gene products.
Bold RJ; Hannink M; Donoghue DJ
Cancer Surv; 1986; 5(2):243-55. PubMed ID: 2946405
[TBL] [Abstract][Full Text] [Related]
19. Detection of RET oncogene activation in human papillary thyroid carcinomas by in situ hybridisation.
Fabien N; Paulin C; Santoro M; Berger N; Grieco M; Galvain D; Barbier Y; Dubois PM; Fusco A
Br J Cancer; 1992 Dec; 66(6):1094-8. PubMed ID: 1457350
[TBL] [Abstract][Full Text] [Related]
20. Introduction of v-Ha-ras oncogene induces differentiation of cultured human medullary thyroid carcinoma cells.
Nakagawa T; Mabry M; de Bustros A; Ihle JN; Nelkin BD; Baylin SB
Proc Natl Acad Sci U S A; 1987 Aug; 84(16):5923-7. PubMed ID: 3112776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
